Mariana Oncology

We’re thrilled to kick off a new season of learning, collaboration, and impact. This talented group from around the country and beyond will join us for an experience filled with learning, collaboration, and scientific impact. Our interns and co-ops are joining us in the pursuit of a more humane and effective approach to cancer treatment.

Happy Independence Day from all of us at Mariana. Today we’re grateful for the freedoms we enjoy and committed to doing our part to ensure access and improved healthcare outcomes for all. #4thofJuly #IndependenceDay

For patients living with cancer, time matters. That’s why we’re focused on early clinical insights that can help accelerate development. Using ligands that are compatible with both imaging and therapeutic isotopes may allow us to evaluate target engagement and radiation dosimetry early, and provides opportunities to identify patients most likely to benefit from treatment with our RLTs. Learn more: https://lnkd.in/e6YpZG4Y

SNMMI 2025 is underway, and we’re energized by the momentum and collaboration happening across the field. Our team is on the ground in New Orleans, engaging with KOLs and exploring the latest advances in nuclear medicine. These conversations are shaping the future of oncology, and we’re excited to be part of it. Let us know if you’re here—we’d love to connect! #SNMMI25 #Oncology

We’re thrilled to announce a significant milestone for Mariana as we expand our headquarters with an additional facility at 500 Forge Road in Watertown, MA! This strategic expansion strengthens our capacity to support early clinical de-risking, accelerate programs, and advance our R&D capabilities. As we continue to innovate at the intersection of radioligand therapies and oncology, this enhanced footprint positions us to advance transformative treatments to patients with critical unmet needs. Learn more: https://lnkd.in/eQsi9XkG #OncologyInnovation #RLT #Biotech #CancerResearch

On June 19, 1865, more than two years after the Emancipation Proclamation, the last enslaved Americans in Galveston, Texas learned they were free. Juneteenth marks that powerful moment of liberation and gives us a chance to reflect on the importance of equal opportunities for everyone. At Mariana, we take this time to honor the voices of all patients and reflect on how we can help shape more inclusive healthcare. #Juneteenth #Oncology

Did you know men are more likely to be diagnosed with small cell lung cancer than women? This Men’s Health Week, we’re shining a light on this disparity and emphasizing how early detection can make a life-saving difference. At Mariana, we’re committed to developing radioligand therapies designed to improve precision and patient selection from the earliest stages. Let’s use this week to raise awareness, prioritize early detection, and accelerate the science that can save lives. #MensHealthWeek #Oncology

Today, on National Cancer Survivors Day, we honor every person who has navigated the challenges of cancer and continues to move forward with resilience and hope. Your courage shapes our commitment, your stories drive our science, and your tenacity fuels our purpose. We celebrate you. We stand with you. We work for you. Because survival should be the norm, not the exception. #NationalCancerSurvivorsDay #Oncology #Innovation

On #InternationalClinicalTrialsDay, we honor the global community of researchers, clinicians, patients, and partners who make clinical innovation possible. This year’s theme, Collaborate. Innovate. Advance., aligns with our belief that real progress for patients comes when we break silos, share insights, and move forward together. Thank you to the investigators, researchers, patients and partners who continue to push the global science community toward the realization of life-changing treatments.

This #NationalWomensHealthWeek, we’re raising awareness of the growing rates of SCLC in women and the urgent need for better diagnostics, treatments, critical in lung cancer care. While the science behind this trend continues to evolve, what’s clear is that increased awareness, earlier detection, and novel treatment options are necessary. We're committed to contributing to that understanding through innovative target discovery and therapeutic development. #Oncology #SCLC #SmallCellLungCancer